Home » News » Page 38

News

Abbott asks FDA to block adalimumab biosimilar

Published on 2012/06/15

Abbott Laboratories (Abbott) submitted a 30-page citizen petition to FDA on 2 April 2012 asking the agency to reject any biosimilar for its rheumatoid arthritis drug Humira (adalimumab). Abbott says t...

21 views

EMA reviews its first biosimilar monoclonal antibody

Published on 2012/06/13

According to EMAâ€™s list of applications for new human medicines under evaluation by the Committee for Medicinal Products for Human Use released in April 2012 the agency will be reviewing a new ...

28 views

Samsung to launch biosimilars by 2015 at half the current prices

Published on 2012/06/11

South Korean electronics giant Samsung told theÂ Financial TimesÂ that it plans to launch biosimilars by 2015 at half the prices that patients in Europe and the US currently pay. The biotechnolog...

23 views

Removal of barriers for the global development of biosimilars

Published on 2012/06/08

At the 2012 Biosimilars Medicines: 10thÂ EGA International Symposium, held in London, UK, on 19â€“20 April 2012; Mr Nils Behrndt (Deputy Head of Cabinet DG Sanco, European Commission) announced...

27 views

Biosimilars dilemma over reference products

Published on 2012/06/06

Global manufacturers of biosimilars have a dilemma on their hands concerning reference products. What to do to reduce the burden of data required in different countries and regions of the world to get...

25 views

EMA publishes procedural advice for biosimilars

Published on 2012/06/04

On 11 April 2012, EMA published a new document on regulatory procedural advice for biosimilars. The guidance brings together a number of regulatory and procedural questions already published on the a...

23 views

FDA approves generic versions of blood thinner clopidogrel

Published on 2012/05/23

On 17 May 2012 FDA announced the approval of a whole host of generics of Sanofi and Bristol-Myers Squibbâ€™s blockbuster blood thinner Plavix (clopidogrel), on day one of patent expiry in the US....

262 views

Bill introduced to ensure generics get 180-day exclusivity

Published on 2012/05/18

Congressman Frank Pallone and Congressman Brett Guthrie introduced a new bill to the US Senate on 29 March 2012 to amend the US Food, Drug and Cosmetic Act in order to ensure that generics manufacture...

41 views

Current and future issues surrounding biosimilars

Published on 2012/05/16

Biological medicines are already becoming an increasingly important part of health care. With patent expiries on originator biological products, biosimilars are also increasingly become a part of this...

31 views

Patients do not talk about generics with doctors

Published on 2012/05/11

One of the main financial concerns expressed by adults in the US is the cost of medications and medical bills, however, despite this fact, very few patients talk about the price of prescription medici...

27 views

Canada drug shortages

Published on 2012/05/07

Sandoz, the generics unit of pharma giant Novartis, is at the centre of Canadian drug shortages, however, the company is assuring Canadians that it will not raise prices of drugs sourced from overseas...

21 views